HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Utilization of cardiac troponin assays in adult and pediatric populations: Guideline recommendations vs. reality.

AbstractOBJECTIVES:
We hypothesized significant gaps remained for cardiac troponin (cTn) utilization in the United States, despite an emerging evidence base and guideline recommendations. We tested this hypothesis and investigated differences and trends between the use of cTn in adult versus pediatric hospitals.
DESIGN AND METHODS:
Individuals were identified by a targeted distribution through personal contact and professional society email lists. Participants completed an online survey (Qualtrics) from 07/15/13 to 07/26/13. The 31-item questionnaire used skipped logic and collected data about the respondent and their institutional cTn clinical practices. Data tabulation and analysis were conducted using Qualtrics and Microsoft Excel.
RESULTS:
A total of 159 unique laboratories responded to the survey, representing primarily adult (81%) versus pediatric (19%) institutions. 59% of laboratories utilize the guideline recommended 99th percentile as the upper reference limit (URL) for cTn, with large variability in reporting practices among users of the same assay. 73% of laboratories reported simultaneous ordering of other cardiac biomarkers with cTn, a majority which included CK-MB. Interpretive comments were used with cTn in 71 laboratories with a significant amount of heterogeneity. Pediatric hospitals reported a lower frequency of cTn orders and were less likely to consider elevated cTn a critical value.
CONCLUSIONS:
Gaps in current utilization and reporting of cTn exist, along with practices inconsistent with clinical guideline recommendations. Implementation of the 99th percentile and serial sampling protocols will be critical to adoption of high-sensitivity cTn assays. Differences in chest pain etiology are the most likely reason for the notable differences between cTn use in adults versus pediatric hospitals.
AuthorsAmy K Saenger, Shannon Haymond
JournalClinical biochemistry (Clin Biochem) Vol. 48 Issue 18 Pg. 1213-8 (Dec 2015) ISSN: 1873-2933 [Electronic] United States
PMID26277635 (Publication Type: Journal Article)
CopyrightCopyright © 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • Troponin I
  • Troponin T
  • Creatine Kinase, MB Form
Topics
  • Adult
  • Biological Assay (statistics & numerical data)
  • Biomarkers (blood)
  • Chemistry, Clinical (methods)
  • Chest Pain (blood, diagnosis)
  • Child
  • Creatine Kinase, MB Form
  • Female
  • Humans
  • Laboratories
  • Male
  • Myocardial Infarction (blood, diagnosis)
  • Practice Guidelines as Topic
  • Sensitivity and Specificity
  • Surveys and Questionnaires
  • Troponin I (blood)
  • Troponin T (blood)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: